Tech Company Financing Transactions

Pelage Pharmaceuticals Funding Round

Arch Venture Partners, GV and Main Street Advisors participated in a $120 million Series B capital raise for Pelage Pharmaceuticals. This venture round was announced by the company on 10/15/2025.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

907 Westwood Boulevard 384
Los Angeles, CA 90024
USA

Phone

Undisclosed

Website

www.pelagepharma.com

Email Address

[email protected]

Overview

At Pelage, our goal is to deliver a clinically-tested treatment grounded in innovative science for all genders, skin types, and hair types. Based on breakthrough discoveries by Pelage co-founders, we activate hair growth through a first-in-class mechanism that targets the metabolism of hair follicle stem cells.?

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Daniel Gil

        

Chief Medical Officer

Qing Weng

        

Co-Founder

Heather Christofk

        

Co-Founder

Michael Jung

        

President

William Lowry

        

Browse more venture capital transactions:

Prev: 10/14/2025: Ryft venture capital transaction
Next: 10/15/2025: Launchpad.build venture capital transaction

Share this article

About Database of VC Transactions

Our team works diligently to document every notable VC transaction. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary